APROKAM

Reason for request

Clinical Benefit

Substantial

Substantial AB

Clinical Added Value

minor

APROKAM 50 mg, powder for solution for injection, provides a minor improvement in actual benefit (IAB IV) compared with standard management of postoperative endophthalmitis associated with cataract surgery.